These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2861651

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Drugs for the prevention of peptic ulcer recurrence.
    Piper DW.
    Drugs; 1983 Nov; 26(5):439-53. PubMed ID: 6315333
    [Abstract] [Full Text] [Related]

  • 23. The medical management of peptic ulcer.
    Shearman DJ, Hetzel D.
    Annu Rev Med; 1979 Nov; 30():61-79. PubMed ID: 45409
    [No Abstract] [Full Text] [Related]

  • 24. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B, Müller P, Dammann HG.
    Fortschr Med; 1984 Jul 12; 102(25-26):683-7. PubMed ID: 6147304
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Drugs for treatment of peptic ulcers.
    Dajani EZ, Trotman BW.
    J Assoc Acad Minor Phys; 1992 Jul 12; 3(3):78-88. PubMed ID: 1353999
    [Abstract] [Full Text] [Related]

  • 28. The evolution of peptic ulcer therapy. A role for temporal control of drug delivery.
    Warner CW, McIsaac RL.
    Ann N Y Acad Sci; 1991 Jul 12; 618():504-16. PubMed ID: 1672498
    [Abstract] [Full Text] [Related]

  • 29. [Conservative therapy of peptic ulcer].
    Neumayr A, Weiss W.
    Wien Med Wochenschr; 1980 Sep 15; 130(17):555-9. PubMed ID: 6893883
    [No Abstract] [Full Text] [Related]

  • 30. Stress ulceration in the intensive care unit: use of H2-receptor antagonists.
    Moore JG.
    Aliment Pharmacol Ther; 1991 Sep 15; 5 Suppl 1():111-9. PubMed ID: 1679669
    [Abstract] [Full Text] [Related]

  • 31. New horizons in the pharmacologic management of peptic ulceration.
    Debas HT, Mulholland MW.
    Am J Surg; 1986 Mar 15; 151(3):422-30. PubMed ID: 2869709
    [Abstract] [Full Text] [Related]

  • 32. Bacterial overgrowth as a consequence of reduced gastric acidity.
    Stockbruegger RW.
    Scand J Gastroenterol Suppl; 1985 Mar 15; 111():7-16. PubMed ID: 2861652
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of gastric acid secretion by selective and nonselective anticholinergics.
    Feldman M.
    Gastroenterology; 1984 Feb 15; 86(2):361-6. PubMed ID: 6360787
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Anti-ulcer therapy. Past to present.
    Bettarello A.
    Dig Dis Sci; 1985 Nov 15; 30(11 Suppl):36S-42S. PubMed ID: 2865091
    [Abstract] [Full Text] [Related]

  • 36. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G, De Natale F, Marino A.
    Clin Ter; 1989 Apr 15; 129(1):3-16. PubMed ID: 2567647
    [Abstract] [Full Text] [Related]

  • 37. [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer].
    Alekseenko SA, Timoshin SS.
    Ter Arkh; 1999 Apr 15; 71(2):23-6. PubMed ID: 10222548
    [Abstract] [Full Text] [Related]

  • 38. [Peptic ulcer: a social and therapeutic problem still current].
    Visconti GP, Spotti D, Vigorelli PE, Geniram A.
    Recenti Prog Med; 1979 Nov 15; 67(5):530-45. PubMed ID: 42955
    [No Abstract] [Full Text] [Related]

  • 39. Non-ulcer dyspepsia.
    Lagarde SP, Spiro HM.
    Clin Gastroenterol; 1984 May 15; 13(2):437-46. PubMed ID: 6146416
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.